Insiders Galapagos NV

Equities

GLPG

BE0003818359

Market Closed - Euronext Amsterdam Other stock markets 16:35:24 27/06/2024 BST			5-day change	1st Jan Change
23.34 ^EUR	-0.26%		-3.95%	-36.90%

06-25	Frontier Medicines Corporation announced that it has received $99.999997 million in funding from a group of investors	CI
06-14	Galapagos Plans to Present 'Encouraging' Results for GLPG5101 in Non-Hodgkin Lymphoma	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Galapagos NV Announces Board Changes	03-27	CI
Galapagos to Divest Jyseleca Business in Biotechnology Shift	01-02	MT
Michele Manto to Join Alfasigma and Resigns from His Position as Chief Commercial Officer and Executive Committee Member At Galapagos	01-02	CI
Galapagos NV Announces Board Changes	20/09/23	CI
Belgian Biotech Company Galapagos Appoints CFO/COO	16/06/23	MT
Galapagos Appoints Thad Huston as CFO, COO	15/06/23	MT
Galapagos Appoints Thad Huston as Chief Operating Officer, Effective from July 1, 2023	15/06/23	CI
Galapagos NV Announces Director Changes	13/06/23	CI
Galapagos COO/CFO to Step Down in June	03/05/23	MT
Galapagos NV Announces the Departure of Bart Filius as Chief Financial Officer, Effective 30 June 2023	02/05/23	CI
Galapagos NV Announces the Departure of Bart Filius as President and Chief Operating Officer, Effective 30 June 2023	02/05/23	CI
Belgian Biotech Galapagos' Chief Medical Officer, Chief Business Officer To Step Down at Year-end	23/12/22	MT
Galapagos NV Announces Changes in the Executive Committee Effective 1 January 2023	22/12/22	CI
Galapagos Names CEO As Chairman Under New Governance Structure	27/04/22	MT
Galapagos NV Announces Executive Appointments	26/04/22	CI
Galapagos Names Former Johnson & Johnson Executive Paul Stoffels CEO; Shares Soar	27/01/22	MT
Galapagos Appoints Former Johnson & Johnson Exec to Succeed Retiring CEO	27/01/22	MT
Drugmaker Galapagos names former J&J exec Paul Stoffels as CEO	26/01/22	RE
Galapagos NV Appoints Paul Stoffels as Chief Executive Officer	26/01/22	CI
Van Herk Investments Provides Nomination Notice to Galapagos NV	02/11/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Galapagos NV

Equities

GLPG

BE0003818359

Insiders

Filters